Search

Xiaoqing Qing Xu

from Monmouth Junction, NJ
Age ~60

Xiaoqing Xu Phones & Addresses

  • 4504 Schindler Dr S, Monmouth Jct, NJ 08852 (609) 275-3612
  • Monmouth Junction, NJ
  • 22 Dogwood Dr, Plainsboro, NJ 08536 (609) 275-3612
  • Raritan, NJ
  • Durham, NC
  • Fort Collins, CO
  • 22 Dogwood Dr, Plainsboro, NJ 08536 (609) 743-2870

Work

Position: Professional/Technical

Education

Degree: Graduate or professional degree

Emails

Resumes

Resumes

Xiaoqing Xu Photo 1

Medicinal Chemist

View page
Location:
22 Dogwood Dr, Plainsboro, NJ 08536
Industry:
Pharmaceuticals
Work:
Johnson & Johnson 2002 - 2010
Senior Associate Scientist

Venenum Biodesign, Llc 2002 - 2010
Medicinal Chemist

American Cyanamid Basf 2000 - 2002
Research Chemist

Rhone-Poulenc Ag 1999 - 2000
Master Research Assistant

Rti International 1998 - 1999
Chemist
Education:
University of Gent 1996 - 1997
Nanjing University 1982 - 1989
Master of Science, Masters, Chemistry
Skills:
Drug Discovery
Medicinal Chemistry
Drug Design
Organic Synthesis
Organic Chemistry
Hplc
Lead Change
Purification
Biotechnology
Pharmaceutical Industry
Lc Ms
Parallel Synthesis
Languages:
Mandarin
English
Xiaoqing Xu Photo 2

Manager

View page
Work:
Cabinet Depot
Manager
Xiaoqing Xu Photo 3

Xiaoqing Xu

View page
Xiaoqing Xu Photo 4

Xiaoqing Xu

View page
Xiaoqing Xu Photo 5

Xiaoqing Xu

View page

Publications

Us Patents

7-Amino Alkylidenyl-Heterocyclic Quinolones And Naphthyridones

View page
US Patent:
7732612, Jun 8, 2010
Filed:
Mar 21, 2005
Appl. No.:
11/084987
Inventors:
Eugene B. Grant - Flemington NJ, US
Mark J. Macielag - Branchburg NJ, US
Steven David Paget - Hillsborough NJ, US
Xiaoqing Xu - Plainsboro NJ, US
Xiaodong Xu - Doylestown PA, US
Assignee:
Janssen Pharmaceutica, N.V. - Beerse
International Classification:
C07D 215/38
US Classification:
546159, 546156
Abstract:
The present invention relates to compounds having a structure according to Formula I.

Benzimidazole Derivatives Useful As Trpm8 Channel Modulators

View page
US Patent:
8242157, Aug 14, 2012
Filed:
Jun 10, 2010
Appl. No.:
12/797743
Inventors:
Michele C. Jetter - Norristown PA, US
Mark J. Macielag - Spring House PA, US
Mingde Xia - New Brunswick NJ, US
Xiaoqing Xu - Plainsboro NJ, US
Assignee:
Janssen Pharmaceutica NV
International Classification:
C07D 401/00
C07D 235/12
C07D 235/22
A01N 43/52
A61K 31/415
US Classification:
514395, 5462734, 5483101
Abstract:
Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula I as follows:.

Benzimidazole Derivatives Useful As Trpm8 Channel Modulators

View page
US Patent:
8450497, May 28, 2013
Filed:
Jun 10, 2010
Appl. No.:
12/797712
Inventors:
Mark J. Macielag - Spring House PA, US
Mingde Xia - New Brunswick NJ, US
Xiaoqing Xu - Plainsboro NJ, US
Assignee:
Janssen Pharmaceutica, NV
International Classification:
C07D 413/00
US Classification:
5483017, 548126
Abstract:
Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula I as follows:.

7-Amino Alkylidenyl-Heterocyclic Quinolones And Naphthyridones

View page
US Patent:
20050101588, May 12, 2005
Filed:
Sep 9, 2004
Appl. No.:
10/937238
Inventors:
Eugene Grant - Flemington NJ, US
Mark Macielag - Branchburg NJ, US
Xiaoqing Xu - Plainsboro NJ, US
Steven Paget - Hillsborough NJ, US
International Classification:
A61K031/519
A61K031/4745
A61K031/4709
C07D487/04
C07D471/02
C07D043/02
US Classification:
514210210, 514259410, 514300000, 514312000, 544279000, 546123000, 546156000
Abstract:
The present invention relates to compounds having a structure according to Formula I wherein n, m, z, R, R, R, R, R, R, A, E, X, Y, a and b are as defined above; or an optical isomer, diastereomer or enantiomer thereof; a pharmaceutically acceptable salt, hydrate, or prodrug thereof.

7-Amino Alkylidenyl-Heterocyclic Quinolones And Naphthyridones

View page
US Patent:
20090156577, Jun 18, 2009
Filed:
Nov 11, 2008
Appl. No.:
12/268529
Inventors:
Benjamin Davis - Birmingham AL, US
Shu-Chen Lin - Doylestown PA, US
Mark J. Macielag - Branchburg NJ, US
Xiaoqing Xu - Plainsboro NJ, US
Xiaodong Xu - Doylestown PA, US
Bin Zhu - Hillsborough NJ, US
International Classification:
A61K 31/5365
C07D 471/04
A61K 31/4375
C07D 401/04
A61K 31/4709
C07D 498/16
US Classification:
51421021, 546123, 514300, 546178, 514312, 544101, 5142302
Abstract:
The present invention relates to compounds having a structure according to Formula (I)wherein n, m, z, R, R, R, R, R, R, A, E, X, Y, a and b are as defined above; or an optical isomer, diastereomer or enantiomer thereof; a pharmaceutically acceptable salt, hydrate, or prodrug thereof.

Benzimidazole Derivatives Useful As Trpm8 Channel Modulators

View page
US Patent:
20130245085, Sep 19, 2013
Filed:
Apr 30, 2013
Appl. No.:
13/873570
Inventors:
- Beerse, BE
Mingde Xia - New Brunswick NJ, US
Xiaoqing Xu - Plainsboro NJ, US
Assignee:
Janssen Pharmaceutica, NV - Beerse
International Classification:
C07D 233/52
US Classification:
514388
Abstract:
Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula I as follows:

Novel Non-Systemic Tgr5 Agonists

View page
US Patent:
20190330191, Oct 31, 2019
Filed:
Jun 29, 2017
Appl. No.:
16/311185
Inventors:
- Lawrence Township NJ, US
Brian F. McGuinness - Plainsboro NJ, US
Xiaoqing Xu - Monmouth Junction NJ, US
Steven G. Kultgen - Hamilton NJ, US
Ellen Sieber McMaster - Langhorne PA, US
James R. Beasley - Doylestown PA, US
Assignee:
Venenum Biodesign, LLC - Lawrence Township NJ
International Classification:
C07D 403/04
C07D 401/04
C07D 401/14
C07D 405/14
C07D 409/14
A61P 3/10
Abstract:
The present invention relates to tricyclic compounds of formula (I) and formula (II), or a pharmaceutically acceptable salt thereof. The present tricyclic compounds are useful non-systemic TGR5 agonists that can be used to treat diabetic diseases in human. The present invention provides a pharmaceutical composition containing tricyclic compounds of formula (I) and formula (II) and a method of making as well as a method of using same in treating patients inflicted with metabolic disorders by administering same. The compounds of the present invention may be used in combination with additional anti-diabetic drugs.

Benzimidazole Derivatives Useful Trpm8 Channel Modulators

View page
US Patent:
20150150882, Jun 4, 2015
Filed:
Feb 10, 2015
Appl. No.:
14/618462
Inventors:
- Beerse, BE
Mingde Xia - Shanghai, CN
Xiaoqing Xu - Plainsboro NJ, US
International Classification:
A61K 31/5383
A61K 31/4184
Abstract:
Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula I as follows:
Xiaoqing Qing Xu from Monmouth Junction, NJ, age ~60 Get Report